Replay available

EQUALS GROUP PLC (EQLS) — Full Year Results

Full Year Results hosted by EQUALS GROUP PLC (LSE: EQLS) on Investor Meet Company, held 2023-03-27.

Mon, March 27, 2023 at 1:00 PMendedReplay
EQUALS GROUP PLC (EQLS) — Full Year Results

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Ian Strafford-Taylor

CEO at EQUALS GROUP PLC

Richard Cooper

CFO at EQUALS GROUP PLC

Replay transcript excerpt

Good afternoon, ladies and gentlemen, welcome to the EQUALS GROUP PLC Full Year Results Investor Presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and can be submitted at any time using the Q and A tab situated on the right hand side of your screen. Just simply type in your questions at any time and press send. The company may not be in a position to answer every question received during the meeting itself. However, given the com the company review all questions submitted today, we'll publish those responses where it's appropriate to do so. Before we begin, we'd like to submit the following poll. If you give that, your attention, I'm sure the company would be most grateful. I'd now like to hand over to Ian Stratford Taylor, CEO. Good afternoon. Thank you, Mark. Welcome, everybody. I'm Ian Stratford Taylor, chief executive, as as Mark just mentioned. And, Richard, perhaps you'd like to introduce yourself too. Yes. Hello, everybody. Good evening. Richard Cooper, CFO here. And thank you all. I realize it's quite late, especially if you're dialing in from, Continental Europe, etcetera. So, thanks for attending. So we'll crack straight into it. So, starting at the beginning, you know, obviously, this is the annual results roadshow. So we'll talk a bit about 2022, and, obviously, there's a lot of focus in terms of what we're doing from here. So I will go over where we sit macro wise and a few highlights from 2022. Richard will then run you through a bit more detail, bringing to life the kind of bridge from 2021 to 2022 in a in a few areas. Some highlights of q one twenty three so far. Suffice to say we've done a lot. And then some looking forward points and then end with a summary. So you may recall in the ...

More from Eql Pharma Ab